Here’s another installment of PubPeer Selections:
- Was a Nature correction to a 2008 paper enough?
- “This might be a bit disappointing for the patients whose macrophages don’t seem to have been used for anything that is going to advance COPD patient care,” says a commenter about a 2011 Journal of Clinical Investigation paper.
- A commenter raises questions about a number of figures in a 2001 Journal of Biological Chemistry paper.
- A 2013 PLOS ONE paper on a Lactobacillus species draws scrutiny.
- Commenters find a number of potential problems in a recently published paper in Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy by a crystallography group whose papers have been criticized elsewhere.
This Nature correction once again shows that Nature is only interested in damage control, and certainly not in any ethics or even reliability of scientific research they choose to publish. Investigating faulty and unreliable papers and dealing with misconduct allegations is apparently bad for business.
Regarding the JCI paper from Dr. Biswal’s group, an NIH reporter search shows that the following grant was completed recently.
“DEVELOPING NRF2 AS A TARGET FOR TREATMENT OF CORTICOSTEROID RESISTANCE IN COPD”
I hope the “alleged” images were not used in the grant application.